Assisted Reproductive Technology Clinical Trial
Official title:
Oocyte Activation: Revised or Initial Activated Gamete Treatment (AGT) Technique, Which is Better?! A Sibling-oocytes-split Design and Case Series of Chemical Pregnancies
NCT number | NCT05113238 |
Other study ID # | 003 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 15, 2021 |
Est. completion date | December 30, 2021 |
Verified date | September 2022 |
Source | Royal Fertility Center, Egypt |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will be conducted to compare two different Assisted Gamete treatment (AGT) with oocyte-sibling-split design control group : AGT- initial protocol for activating oocytes by culturing oocytes in calcium ionophore after injection for two rounds of 10 minutes at 37 C, 30 minutes after injection. sample group : AGT-revised protocol oocytes will be injected by sperm previously cultured in Ca ionophore and 0.4 pL of calcium ionophore then will be cultured in calcium ionophore after injection for 10 minutes
Status | Completed |
Enrollment | 222 |
Est. completion date | December 30, 2021 |
Est. primary completion date | December 25, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - couples presented with an extremely poor fertilization (<10%) - couples with previous complete fertilization failure after undergoing ICSI cycles - At least 4 MII oocytes - Severe oligoasthinozoospermia - Teratozoospermia - testicular aspirated sperm Exclusion Criteria: - age >40 years - BMI >34 - aspirated oocytes < 4 - Normozoospermia - subfertile patients |
Country | Name | City | State |
---|---|---|---|
Egypt | Royal Fertility Center | Mansoura | Daqahlya |
Lead Sponsor | Collaborator |
---|---|
Royal Fertility Center, Egypt | Hawaa Fertility Center |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of top quality day 3 embryos | number of top quality embryos | 3 days after ICSI procedure day | |
Primary | Number of Top quality day 4 embryos | number of top quality embryos | 4 days after ICSI procedure | |
Primary | Number of Top quality day 5 embryos | number of top quality embryos | 5 days after ICSI procedure | |
Secondary | chemical pregnancy rate | the number of positive pregnancy cases from overall cases | 15 days after embryo transfer procedure day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05113225 -
Sperm Micro-swim up Technique; Process and Select in the Same Dish: a Sibling-oocyte-split Design
|
N/A | |
Completed |
NCT03881072 -
Evaluating the Endometrial Receptivity of FET Patient by Ultrasounicelastography
|
N/A | |
Recruiting |
NCT04897269 -
Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day
|
Phase 3 | |
Completed |
NCT02190422 -
Effect of Assisted Reproductive Technology on Cardiac Development in Childhood Assessed by Echocardiography
|
N/A | |
Recruiting |
NCT06238570 -
Validation of Donor Oocytes Semi-automated Vitrification
|
N/A | |
Recruiting |
NCT03756857 -
Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization?
|
N/A | |
Terminated |
NCT03386227 -
Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT
|
N/A | |
Completed |
NCT02171884 -
Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans
|
||
Not yet recruiting |
NCT05164029 -
The Clinical Cohort Study of Reproductive Health
|
||
Active, not recruiting |
NCT05404464 -
Construction of CITIC Xiangya Assisted Reproduction Data Repository
|
||
Active, not recruiting |
NCT02109900 -
Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome
|
N/A | |
Active, not recruiting |
NCT04741295 -
Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome
|
N/A | |
Not yet recruiting |
NCT05738382 -
Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures
|
Phase 2 | |
Withdrawn |
NCT02520869 -
Diagnostic Value of Sperm DNA Fragmentation and Sperm Morphology for Assisted Reproduction Treatment
|
Phase 2/Phase 3 |